Total, longitudinal and transverse body sizes in men with psoriasis of different somatotypes
Abstract
Using a constitutional approach to predict the onset of a disease can be key not only to solving the problem of late-stage lifestyle modification therapy but also to understanding the deep, seemingly incomprehensible links between organs and body structure. The aim of the study was to establish and analyze the differences in total, longitudinal and transverse body sizes between healthy and/or psoriatic men of different somatotypes depending on the severity of the disease. Anthropo-somatotypological examination was performed on Ukrainian men (aged 22 to 35 years) with psoriasis (n=100, including 32 with mild and 68 with severe). A clinical assessment of the severity and area of psoriatic lesions was performed using the PASI index. Anthropometric data of 82 practically healthy men of the same age group was taken from the data bank of the research center of National Pirogov Memorial Medical University, Vinnytsya. Statistical processing of the obtained results was performed in the license package “Statistica 5.5” using non-parametric evaluation methods. In patients with mild and severe psoriasis, men of mesomorphic and endo-mesomorphic somatotypes in comparison with healthy men of the corresponding somatotypes, higher values of almost all total (in the endo-mesomorphs with severe disease), transverse (except for shoulder width) and lateral body size (except endo-mesomorphs with severe disease) was found. In patients with psoriasis, men of endo-mesomorphic somatotype with a mild course of the disease found greater than in patients with a similar course men of mesomorphic somatotype, body weight, length and surface area, height of acromial and finger anthropometric points, and transverse middle thoracic diameters and anteroposterior middle thoracic diameter; and in patients with psoriasis men of endo-mesomorphic somatotype with a severe course of the disease – only greater values than in patients with a similar course of the disease men of mesomorphic somatotype, interspinous distance. When comparing the total, longitudinal and transverse dimensions of the body between men with psoriasis of the corresponding somatotypes, in representatives of the mesomorphic somatotype with a mild course of the disease found greater than with severe course, body length values and lower – posterior middle thoracic diameter. The revealed differences in total, longitudinal and transverse body sizes between healthy and/or patients with mild or severe psoriasis Ukrainian men of mesomorphic and endo-mesomorphic somatotypes provide an opportunity to increase the effectiveness of the use of body structure and size to identify risk groups psoriasis.
References
[2] Armstrong, A. W., Mehta, M. D., Schupp, C. W., Gondo, G. C., Bell, S. J., & Griffiths, C. E. (2021). Psoriasis prevalence in adults in the United States. JAMA Dermatology, 157(8), 940-946. doi: 10.1001/jamadermatol.2021.2007
[3] Augustin, M., Krüger, K., Radtke, M. A., Schwippl, I., & Reich, K. (2008). Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology, 216(4), 366-372. doi: 10.1159/000119415
[4] Becker, L., Tom, W. L., Eshagh, K., Benjamin, L. T., & Paller, A. S. (2014). Excess adiposity preceding pediatric psoriasis. JAMA Dermatology, 150(5), 573-574. doi: 10.1001/jamadermatol.2014.324
[5] Blake, T., Gullick, N. J., Hutchinson, C. E., & Barber, T. M. (2020). Psoriatic disease and body composition: A systematic review and narrative synthesis. Plos One, 15(8), e0237598. doi: 10.1371/journal.pone.0237598
[6] Bunak, V. V. (1941). Antropometriia [Anthropometry]. М.: Narkompros RSFSR – М.: People’s Commissariat of the RSFSR.
[7] Carter, J. (2003). The Heath-Carter antropometric somatotype. Instruction manual. Department of Exercise and Nutritional Sciences San Diego State University. CA. U.S.A.
[8] Chahoud, J., Semaan, A., Chen, Y., Cao, M., Rieber, A. G., Rady, P., & Tyring, S. K. (2016). Association Between Pediatric Psoriasis and Waist-to-Height Ratio in the Absence of Obesity: A Multicenter Australian Study. JAMA Dermatology, 152(12), 1354-1364.
[9] Danielsen, K., Olsen, A. O., Wilsgaard, T., & Furberg, A. S. (2013). Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. British Journal of Dermatology, 168(6), 1303-1310. doi: 10.1111/bjd.12230
[10] Danielsen, K., Wilsgaard, T., Olsen, A. O., & Furberg, A. S. (2017). Overweight and weight gain predict psoriasis development in a population-based cohort. Acta Dermato-venereologica, 97(3), 332-339.
[11] Ding, X., Wang, T., Shen, Y., Wang, X., Zhou, C., Tian, S. ... Zhang, J. (2012). Prevalence of psoriasis in China: a population-based study in six cities. European Journal of Dermatology, 22(5), 663-667. doi: 10.1684/ejd.2012.1802
[12] Dmytrenko, S. V., Obadeh Bassam Abdel-Rahman Al-Qaraleh, Dzevulska І. V., Skoruk, R. V., & Gunas, I. V. (2020). Features of total, longitudinal and transverse body sizes in men of the general group of patients with mild and severe psoriasis. Вісник Вінницького національного медичного університету – Bulletin of Vinnytsia National Medical University, 24(4), 647-652. doi: 10.31393/reports-vnmedical-2020-24(4)-15
[13] Egeberg, A., Skov, L., Gislason, G. H., Thyssen, J. P., & Mallbris, L. (2017). Incidence and prevalence of psoriasis in Denmark. Acta Dermato-venereologica, 97(6-7), 808-812.
[14] Farley, E., & Menter, A. (2011). Psoriasis: comorbidities and associations. Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa italiana di dermatologia e sifilografia, 146(1), 9-15. PMID: 21317853
[15] Ferguson, L. D., Brown, R., Celis-Morales, C., Welsh, P., Lyall, D. M., Pell, J. P. ... Sattar, N. (2019). Association of central adiposity with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional study of the UK Biobank. Rheumatology, 58(12), 2137-2142. doi: 10.1093/rheumatology/kez192
[16] Fredriksson, T., & Pettersson, U. (1978). Severe psoriasis – oral therapy with a new retinoid. Dermatology, 157(4), 238-244. doi: 10.1159/000250839
[17] Lakshmy, S., Balasundaram, S., Sarkar, S., Audhya, M., & Subramaniam, E. (2015). A cross-sectional study of prevalence and implications of depression and anxiety in psoriasis. Indian Journal of Psychological Medicine, 37(4), 434-440. doi: 10.4103/0253-7176.168587
[18] Mahé, E., Beauchet, A., Bodemer, C., Phan, A., Bursztejn, A. C., Boralevi, F. ... Groupe de Recherche de la Société Française de Dermatologie Pédiatrique. (2015). Psoriasis and obesity in French children: a case-control, multicentre study. British Journal of Dermatology, 172(6), 1593-1600. doi: 10.1111/bjd.13507
[19] Mishalov, V. D., & Gunas, V. І. (2018). Discriminating models of dermatoglyphic priority of practically healthy men to southern or other administrative-territorial regions of Ukraine. Forensic-medical Examination, (1), 17-21. doi: 10.24061/2707-8728.1.2018.6
[20] Ozkaya, D. B., Onsun, N., Topukçu, B., Su, O., Bahalı, A. G., Dizman, D., ... & Uysal, O. (2016). The relationship between body mass index, waist circumference and psoriatic arthritis in the Turkish population. Advances in Dermatology and Allergology / Postȩpy Dermatologii i Alergologii, 33(3), 219-223. doi: 10.5114/ada.2016.60615
[21] Paller, A. S., Mercy, K., Kwasny, M. J., Choon, S. E., Cordoro, K. M., Girolomoni, G., ... & Seyger, M. M. (2013). Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. JAMA Dermatology, 149(2), 166-176. doi: 10.1001/jamadermatol.2013.1078
[22] Romiti, R., Amone, M., Menter, A., & Miot, H. A. (2017). Prevalence of psoriasis in Brazil–a geographical survey. International Journal of Dermatology, 56(8), e167-e168. doi: 10.1111/ijd.13604
[23] Sampogna, F., Tabolli, S., & Abeni, D. (2012). Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life. Acta Dermato-venereologica, 92(3), 299-303.
[24] Snekvik, I., Nilsen, T. I. L., Romundstad, P. R., & Saunes, M. (2019). Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway. British Journal of Dermatology, 180(1), 94-99. doi: 10.1111/bjd.16885
[25] Springate, D. A., Parisi, R., Kontopantelis, E., Reeves, D., Griffiths, C. E. M., & Ashcroft, D. M. (2017). Incidence, prevalence and mortality of patients with psoriasis: a UK population-based cohort study. British Journal of Dermatology, 176(3), 650-658. doi: 10.1111/bjd.15021
[26] Thomsen, R. S., Nilsen, T. I., Haugeberg, G., Gulati, A. M., Kavanaugh, A., & Hoff, M. (2021). Adiposity and physical activity as risk factors for developing psoriatic arthritis: longitudinal data from a Population-Based study in Norway. Arthritis Care & Research, 73(3), 432-441. doi: 10.1002/acr.24121

This work is licensed under a Creative Commons Attribution 4.0 International License.